Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: September 2024
Sep 25, 2024
Federal and international law and policy insights, news and events from Vicente LLP
Sep 25, 2024
Federal and international law and policy insights, news and events from Vicente LLP
By Jason Adelstone
Sep 9, 2024
The DEA Hearing on Proposed Rulemaking for cannabis rescheduling will take place on December 2, 2024. What happens next? Read this insights article to learn about the importance of "interested persons" and the administrative law judge appointed to oversee the hearing, the anticipated timeline, the potential impact of the presidential election, and more.
By Shawn Hauser
Aug 1, 2024
Last Monday marked the end of the historic DEA public comment period for marijuana’s proposed rescheduling to Schedule III. What happens now and how might election dynamics have an impact?
Jun 13, 2024
Federal and international law and policy insights, news and events from Vicente LLP
May 3, 2024
Watch this special briefing featuring Vicente LLP leaders who have been deeply immersed in the federal scheduling issue, along with Mitzi Keating, a CPA and partner at Citrin Cooperman.
By Andrew Livingston, Jason Adelstone, Shawn Hauser
Apr 30, 2024
After 50 years of being in the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana from Schedule I to Schedule III, where the plant’s medical benefits will finally be recognized by the federal government. Read this article for answers to four of the most important questions about the effects Schedule III will have on cannabis and society.
Feb 20, 2024
Federal and international law and policy insights, news and events from Vicente LLP
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.